스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - klysmen - mesalazinum 2 g, xanthani gomme, carbomerum 934, dinatrii edetas, kalii acetas, e 224, e 211 30 mg, aqua purificata q.s. la suspension de 30 g, pour le navire. - la colite ulcéreuse - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - mesalazinum - mousse rectale - mesalazinum 2 g, antiox.: e 224, conserv.: e 211, excipiens à la suspension et propellentia pour la dosi. - colite ulcéreuse - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - mesalazinum - mousse rectale - mesalazinum 4 g antiox.: e 224, conserv.: e 211, excipiens à la suspension et propellentia pour la dosi. - colite ulcéreuse - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - budesonidum - lavement - i) dispergierbare tablette: budesonidum 2.3 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas pro compresso. ii) vehikel: e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad solutionem pro 100 ml. suspensio reconstituta: budesonidum 2 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas, e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad suspensionem pro 100 ml. - la colite ulcéreuse - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - mesalazinum - comprimé gastro-résistant - mesalazinum 400 mg, lactosum monohydricum 76.4 mg, carboxymethylamylum natricum a corresp. natrium 0.768 mg, magnesii stearas, talcum, povidonum k 25, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, triethylis citras, macrogolum 6000, e 172, pro compresso obducto. - la colite ulcéreuse - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - mesalazinum - magensaftesistente comprimé - mesalazinum 800 mg, lactosum monohydricum 153 mg, carboxymethylamylum natricum a corresp. natrium 1.537 mg, magnesii stearas, talcum, povidonum k 25, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, triethylis citras, macrogolum 6000, e 172, pro compresso obducto. - la colite ulcéreuse - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - budesonidum - capsules - budesonidum 3 mg, sacchari sphaerae corresp. saccharum 276 mg et maydis amylum, lactosum monohydricum 12 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, kapselhülle: gelatina, e 172 (rubrum), e 171, e 127, e 172 (nigrum), natrii laurilsulfas corresp. natrium 0.006 mg, pro capsula. - morbus chron, kollagene colitis - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - budesonidum - hartkapsel mit veränderter wirkstofffreisetzung - budesonidum 3 mg, tributylis acetylcitras, simeticonum, ethylcellulosum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, polysorbatum 80, sacchari sphaerae 320 mg, talcum, triethylis citras, kapselhülle: gelatina, paraffinum liquidum, silica colloidalis anhydrica, natrii laurilsulfas corresp. natrium 11.96 µg, e 171, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), drucktinte: ammonii hydroxidum, e 172 (nigrum), kalii hydroxidum, lacca, pro capsula. - morbus crohn, mikroskopische kolitis - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

ferring ag - mesalazinum - depot-granulat - mesalazinum 1 g, povidonum, ethylcellulosum, ad granulatum pro charte. - la colite ulcéreuse - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

ferring ag - mesalazinum - depot-granulat - mesalazinum 2 g, povidonum, ethylcellulosum, ad granulatum pro charte. - la colite ulcéreuse - synthetika